News and insights
Fibrodysplasia ossificans progressiva (FOP) insights
From soft-tissue to bone: Clinical presentation of fibrodysplasia ossificans progressiva (FOP)
Welcome to the first of a series of 4 spotlight articles about FOP, its impact on patients’ quality of life, and its associated pathways to care
The unpredictable nature of flare-ups in fibrodysplasia ossificans progressiva (FOP)
In this recent edition from the series, find out how to recognise and identify the effects of flare-ups in fibrodysplasia ossificans progressiva (FOP), and test your knowledge in our short quiz.
Impact of inappropriate care and disability accumulation on quality of life in FOP
Welcome to the third spotlight article in a series on FOP and its associated pathways of care
Biosimilars insights
Biosimilars: an option to alleviate the heavy burden of immune-mediated inflammatory diseases
Developed by EPG Health for Medthority in collaboration with Biogen®. This content is intended for healthcare professionals only, and it has been funded and reviewed by Biogen® for scientific accuracy.
Clinical value beyond price alone: biosimilars improve patient access to treatment
Developed by EPG Health for Medthority in collaboration with Biogen®. This content is intended for healthcare professionals only, and it has been funded and reviewed by Biogen® for scientific accuracy.
Clinical value beyond price alone: anti-TNF biosimilars enable early treatment
Developed by EPG Health for Medthority in collaboration with Biogen®. This content is intended for healthcare professionals only, and it has been funded and reviewed by Biogen® for scientific accuracy.